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Abstract
We compared the treatment planning performance of RapidArc (RA) vs. CyberKnife (CK)
for spinal stereotactic body radiation therapy (SBRT). Ten patients with spinal lesions who had 
been treated with CK were re-planned with RA, which consisted of two complete arcs.
Computed tomography (CT) and volumetric dose data of CK, generated using the Multiplan 
(Accuray) treatment planning system (TPS) and the Ray-Trace algorithm, were imported to 
Varian Eclipse TPS in Dicom format, and the data were compared with the RA plan using 
analytical anisotropic algorithm (AAA) dose calculation. The optimized dose priorities for both 
CK and RA plans were similar for all patients. The highest priority was to provide enough dose 
coverage to the planned target volume (PTV) while limiting the maximum dose to the spinal 
cord. Plan quality was evaluated with respect to PTV coverage, conformity index (CI), high-dose 
spillage, intermediate-dose spillage (R50% and D2cm), and maximum dose to the spinal cord,
which are criteria recommended by RTOG 0631 spine and 0915 lung SBRT protocols.
The mean CI ± SD values of PTV were 1.11 ± 0.03 and 1.17 ± 0.10 for RA and CK (p = 
0.02), respectively. On average, the maximum dose delivered to the spinal cord in CK plans was 
approximately 11.6% higher than in RA plans, and this difference was statistically significant
(p < 0.001). High-dose spillages were 0.86% and 2.26% for RA and CK (p = 0.203), respectively. 
Intermediate-dose spillage characterized by D2cm was lower for RA than for CK; however, R50%
was not statistically different. Even though both systems can create highly conformal volumetric 
dose distributions, the current study shows that RA demonstrates lower high- and intermediate-
dose spillage than CK. Therefore, RA plans for spinal SBRT may be superior to CK.
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I. Introduction
Up to 40% of cancer patients develop spinal metastasis [1] , and radiation therapy (RT) is 
a well-established treatment for spinal tumors. Palliative RT with conventional techniques can 
effectively control pain [2, 3], but spinal metastases often recur because spinal cord tolerance 
limits the administered dose [4]. Accordingly, spinal stereotactic body radiotherapy (SBRT), 
which delivers a high radiation dose in a single or limited number of fractions within a small 
target volume, is the best approach for increasing local control because it minimizes the dose to 
the adjacent spinal cord while maximizing the dose delivered to the tumor region. This technique 
therefore can also significantly reduce radiation-induced myelopathy [5, 6].
Spinal SBRT can be performed using either a linear accelerator-based multileaf 
collimator (MLC) or a frameless real-time tumor tracking-supported CyberKnife (CK). CK can 
deliver multiple non-isocentric beams by 6 MV linear accelerator to the desired target. This 
system uses two ceiling-mounted diagnostic kV imagers to monitor the patient’s position and 
track the tumor throughout treatment [7-9]. Volumetric-modulated arc radiotherapy (VMAT) can
deliver highly conformal radiation doses in 1–5 fractions under image guidance by gantry 
rotation of the linear accelerator [10-12]. However, since these two modalities have different 
characteristics, they can result in different dose distributions. To address the different dosimetric 
characteristics of linear accelerator-based SBRT and CK, we directly compared the RapidArc 
(RA) plan with the CK plan for spinal SBRT, and evaluated plan quality using the conformity 
index (CI) and several SBRT-specific dose gradient indices.
II. Materials and Methods
Treatment planning
Ten patients with spinal lesions (one patient with C-spine, four patients with T-spine, and 
five patients with L-spine), treated using CK at Asan Medical Center from January to June 2014,
were retrospectively analyzed. The total prescribed dose was 18–26 Gy for 3–4 fractions, and the 
average dose per fraction was 6.5 Gy (range = 6–8 Gy). The CK plans were generated with a 
planning Computed tomography (CT) images (1.25 mm thick slices) using the Multiplan 
(Accuray Inc., Sunnyvale, CA) treatment planning system (TPS). One to three different sizes of 
fixed collimators and between 150 and 247 beams were used to fully cover the target. Dose 
distribution was calculated by the Ray-Trace algorithm. 
The CK plans were re-planned with RA consisting of two complete arcs. For RA plan, 
the CT data with the calculated dose volume were imported into the Varian Eclipse TPS (version
10.0) in Dicom format and then compared with those of RA plans. The isocenter was set to the 
center of the planning target volume (PTV). Two complete arcs (clockwise rotation from 181–
179° with the collimator at 30°, and counterclockwise rotation from 179–181° with the 
collimator at 330°) were applied to all RA plans. A single arc is consisted of 178 control points, 
roughly every 1, to cover the PTV by moving the gantry at the maximum speed to minimize the 
treatment time. The RA plans were calculated using Eclipse (version 10.0.28) analytical 
anisotropic algorithm (AAA) dose calculation with a grid size of 1.25 mm. 10-MV flattening-
filter-free beams of a TrueBeam accelerator equipped with a high-definition 120 multileaf 
collimator (Varian Medical System, Palo Alto, CA) were used. Optimization constraints were set 
to produce dose distributions that met the criteria of the RTOG protocols [13, 14]. The optimized
dose priorities were similar for all cases. Providing enough dose coverage to the PTVs and 
limiting the maximum dose to the spinal cord were the highest priorities. Normalization was 
required for 97–100% of the isodose line to ensure the prescribed dose covered 95% of the PTV.
Great care was needed to optimize the treatment plan: the dose constraint was < 0% for the 
spinal cord volume receiving 16 Gy (V0% <16 Gy). The monitor units per fraction and the 
estimated delivery time were summarized for each patient in Table 1. The monitor units per 
fraction ranged from 1943 to 5971 for RA plan and from 8785 to 21872 for CK plan, 
respectively. The average estimated treatment times were 4.1 1.4 and 59.8 4.1 minutes for RA 
and CK, respectively.
Table 1. Summary of monitor units and beam-on time per fraction of CyberKnife and RapidArc for ten patients 
Dose per 
fraction [Gy]
No. of beams
for CK
Monitor Units /Fraction Treatment Time/ Fraction [min]
Patient No. RA CK RA CK
1 8 181 5971 15915 6.5 66
2 6 172 3830 10550 4.2 58
3 6.5 163 3897 11698 4.3 58
4 6.5 154 3492 11181 3.8 58
5 6.5 170 5933 11773 6.5 60
6 6.5 177 3678 12521 4.0 63
7 6 195 3111 11450 3.4 62
8 6.5 150 2846 8785 3.1 52
9 6.5 186 3304 12843 3.6 64
10 8 247 1943 21872 2.1 57
Mean  SD 179.5  27.5 3801  1268 12859  3651 4.1 1.4 59.8  4.1
Dosimetric parameters
The parameters used to evaluate plan quality included target volume coverage, CI, high-
dose spillage, intermediate-dose spillage (R50% and D2cm), and maximum dose administered to the 
spinal cord, as recommended by the RTOG 0631 spine and 0915 lung SBRT protocols [13-15].
CI was defined as the ratio of PTV covered by the prescribed dose (PTV Vprescribed dose) to PTV.
Acceptable conformity was defined as <1.2, according to the RTOG 0915 protocol [14]. High-
dose spillage was calculated as the ratio of volume outside the PTV that received >105% of the 
prescribed dose to PTV volume (V [V105% - PTV] / [PTV]). As shown in Figure 1, intermediate-
dose spillage was defined as the fall-off gradient located outside of the PTV. Intermediate-dose 
spillages were expressed as R50% (volume that received 50% of the prescribed dose/PTV volume) 
and D2cm (maximum dose in terms of the percentage of the prescribed dose at 2 cm beyond PTV 
in any direction). The accepted values for R50% and D2cm varied depending on the PTV volume
[14].
To evaluate the characteristics of each modality with respect to dose distribution, the dose 
distributions of the two plans were directly subtracted (RA - CK), from which dose difference 
patterns were observed when the RA plan was higher and lower doses than the CK plan, 
separately.
Statistical analysis
First, the Kolmogorov–Smirnov test [16] was used to determine whether the dosimetric 
parameters used for RA and CK plans were normally distributed or not. CI and high-dose 
spillage were analyzed using the Wilcoxon signed-rank test [16], and intermediate-dose spillage 
and the spinal cord dose were analyzed using the paired t-test (SPSS Statistics, version 18, IBM, 
NY). In this study, p < 0.05 was considered statistically significant.
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III. Results
Target volume coverage
The dose distribution within the PTV was assessed by evaluating the maximum, 
minimum, and mean doses. The CK plans consistently exhibited high mean and maximum doses
in the PTV, and the volumes of the 100% prescribed doses are summarized in Table 2. The 
maximum dose was within the PTV for all plans. Figure 2 shows a representative DVH of the 
RA and CK plans. The RA plan produced better PTV coverage. Figure 3 compares the dose 
distribution and PTV coverage of the RA vs. CK plans in three directions. For the RA plan, the 
entire dose was homogeneously distributed within the PTV. The mean CI ± SD of PTV for the 
RA and CK plans were 1.11 ± 0.03 (range = 1.07–1.16) and 1.17 ± 0.10 (range = 1.09–1.42), 
respectively (Table 3). Three CK plans demonstrated CI values >1.2, whereas all RA plans had 
CI values <1.2; however, the two plans did not demonstrate statistically significant differences in 
conformity (p = 0.074). 
Dose gradient
High-dose spillages were 0.86 ± 1.30% for RA and 2.26 ± 4.21% for CK (p = 0.203), as
shown in Table 2. Intermediate-dose spillages, as characterized by D2cm, were lower for RA than
for CK (p = 0.001); however, R50% did not show a statistically significant difference.
Dose difference
When subtracting the dose distribution of CK from RA, (RA - CK), the trace of the 
oblique incidence by the non-coplanar beams was within the range of the negative values (shown 
in pink); however, the pattern of the coplanar beams using both complete arcs was greater than 0
(shown in green) (Figure 4). The CK plan resulted in a higher dose than the RA plan inside and 
near the PTV, whereas the dose for the RA plan was distributed throughout the entire body.
Normal tissue sparing
DVHs were used to compare the maximum doses to the spinal cord (Figure 2). Eight CK 
plans exhibited higher doses than that of RA plans, and the average maximum dose to the spinal 
cord using CK was approximately 11.6% higher than when using RA (Figure 2 and Table 3). 
This difference was statistically significant (p = 0.014). Figure 5 compares the dose profiles for 
Patient #3. Vertical and horizontal lines were drawn through the center of the spinal cord for
each plan. The vertical and horizontal dose profiles for RA (red line), CK (blue line), and 
differences between the two plans (pink line) are shown in Figures 5 (c–d). The spinal cord is
highlighted by the blue box. The maximum doses to the spinal cord were 1957.6 and 1532.0 cGy 
for CK and RA, respectively. The RA plan resulted in steep dose gradients just outside the target, 
and thus resulted in a smaller dose to the spinal cord.
Table 2. Summary of target dosimetric parameters for ten patients using CyberKnife and RapidArc.
Patient
No.
PTV [cc]
Dmin [cGy] Dmean [cGy] Dmax [cGy] V100% [cc]
RA CK RA CK RA CK RA CK
1 44.4 2125.1 1856.4 2584.2 2762.0 2866.0 3076.9 49.1 62.9
2 93.1 1699.0 1637.0 1934.6 1989.9 2149.8 2222.2 99.4 104.9
3 110.0 2449.4 2010.3 2789.6 2901.7 3141.9 3291.1 120.5 124.2
4 55.8 2405.8 2141.1 2811.3 2853.3 3153.1 3250.0 61.1 61.0
5 106.6 2217.4 1792.8 2816.4 2879.8 3195.8 3209.9 123.8 129.6
6 99.4 2439.6 1887.4 2819.5 2888.4 3141.4 3209.9 113.5 120.3
7 55.3 2142.6 1479.1 2560.8 2584.0 2870.9 2963.0 64.1 60.1
8 124.1 2503.8 2122.7 2788.6 2846.0 3031.4 3291.1 135.7 140.4
9 50.6 2162.3 1366.0 2798.6 2807.4 3071.2 3250.0 57.2 60.3
10 12.4 1772.1 1360.5 2610.0 2651.9 2901.2 3116.9 13.4 13.8
Average 2191.7 1765.3 2651.4 2716.4 2952.3 3088.1 83.8 87.8
SD 278.5 293.4 272.6 276.1 307.8 321.6 40.2 41.5
PTV, planning target volume; V100%, the volumes of PTV receiving the 100% prescribed dose.
Figure 2. DVH for RapidArc (■
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Figure 3. Dose distribution and PTV coverage of RapidArc vs. CyberKnife in axial (A, D), 
coronal (B, E), and sagittal (C, F) sections. The PTV is outlined in pink. RA doses were 
uniformly distributed inside the PTV and avoided the spinal cord (cyan).
Table 3. Dosimetric parameter results for the target and organ at risk.
Parameter RapidArc CyberKnife p-value
Conformity
R100% 1.11 ± 0.03 1.17 ± 0.10 0.074
High-dose spillage
0.86 ±1.30 2.26 ± 4.21 0.203
Intermediate-dose spillage
R50% 4.61 ± 1.85 5.32 ± 0.97 0.074
D2cm 57.42 ± 7.38 72.56 ± 16.13 0.001*
Spinal cord
Dmax [cGy] 1577.57 ± 74.96 1909.10 ± 60.95 0.000*
Rxx%, ratio of the percentage of the prescribed dose volume/PTV volume; D2cm, maximum dose 
in % of prescription dose at 2 cm beyond the PTV in any direction.
*Statistically significant (p < 0.05).
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IV. Discussion and Conclusion
Conventional RT is a common way to effectively control pain in patients with spinal 
metastasis. However, in conventional RT, the full dose can result in delivery of radiation to
vertebral bodies, including the spinal cord, which are not resistant to high-dose radiation. SBRT 
is applied to treat spinal tumors and deliver high doses to control tumors, reduce the retreatment
rate, and prevent spinal cord compression. SBRT has promising advantages over conventional 
RT for use in palliation regimens [17]. SBRT has also been performed in combination with 
various systems that have different characteristics, including robotic linear accelerators. Both 
CyberKnife and Varian RapidArc are used at our institution. Many facilities use these techniques;
however, direct dosimetric comparisons between CK and RA plans have not been reported. 
In our current analyses, we directly compared these two systems in terms of plan quality 
using several dosimetric indices according to RTOG protocols. Although both systems 
demonstrated good abilities and highly conformal volumetric dose distributions, RA 
demonstrated lower high- and intermediate-dose spillage than CK. According to the subtracted 
dose distribution, both plans had sharp dose gradients outside the target; however, as shown in 
Figure 5, spinal cord regions were more effectively protected with the RA plan, which has a 
lower maximum dose and steeper dose gradient than the CK plan. All patients treated by CK
received a higher maximum dose to the spinal cord in comparison with RA (approximately 11.6%
higher). The maximum dose received by the spinal cord may be related to the functions of 
several parameters, including target volume and the proximity of the spinal cord to the target.
The major features of RA are uniform dose distributions within the PTV and higher 
conformity. More importantly, it avoids high-dose delivery to the spinal cord, which can be 
attributed to the use of arc therapy and flattening filter-free beams that provide steep dose fall-off
profiles and less dependence on field size. In addition, flattening filter-free beams increase the 
dose rate by up to 2400 MU/minute, allowing for shorter treatment times, greater cell killing, and 
more potent biological effects [18]. The high spatial resolution of the multileaf collimator (2.5 
mm wide in the central 8 cm at the isocenter) improves conformity in comparison with the more 
heterogeneous dose distribution of cone-based CK. Similar results were recently reported; 
specifically, RA was shown to be more attractive than CK in terms of dosimetric distribution and 
shorter treatment times in patients with prostate metastasis [19].
It should be mentioned that in this study 3-mm PTV margin is applied for the CK 
treatment, while no PTV margin is recommended by RTOG 0631 assuming no setup error for 
single fraction radiosurgery treatment [13, 20, 21]. Since 3 or 4 fractionations are used in our 
institution, 3 mm PTV margin is applied in practice to take into account inter-fractional setup 
variations. With improved accuracy of image guidance using CBCT, PTV margin for RA would 
be similar as that of CK.
In conclusion, it appears that RA in combination with two complete coplanar arcs 
achieves better plan quality, reduces the dose to the spinal cord, and provides adequate target 
coverage with slightly better CI values than CK, although not every index revealed statistical 
significance. Therefore, RA for spinal SBRT may demonstrate additional dosimetric advantages
that could lead to clinical benefits. 
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